This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Educational Activity

Overview of Treatment Options in Multiple Sclerosis

Emmanuelle Waubant, MD, PhD

Published: June 15, 2012

Article Abstract

Multiple sclerosis (MS) is an autoimmune disorder of the central nervous system that results in inflammation, demyelination, and axonal and neuronal loss. The typical course of MS is one of symptom exacerbations followed by periods of remission; however, patients will eventually accrue disability from the exacerbations. Several drugs, including interferon beta, glatiramer acetate, natalizumab, and fingolimod, are effective in lowering relapse rates and slowing the progression of MS. For patients with suboptimal response to medication, switching to another first- or second-line medication can be an effective strategy.


This CME activity is expired. For more CME activities, visit
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

Related Articles

Volume: 73

Quick Links: